An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement
Yıl: 2022 Cilt: 70 Sayı: 2 Sayfa Aralığı: 203 - 205 Metin Dili: İngilizce DOI: 10.5578/tt.20229811 İndeks Tarihi: 06-07-2022
An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. McDonald LT. Healing after COVID-19: Are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol 2021; 320(2): L257-L265. https://doi.org/10.1152/ ajplung.00238.2020
- 2. Kallet RH, Matthay MA. Hyperoxic acute lung injury. Respir Care 2013; 58(1): 123-41. https://doi.org/10.4187/ respcare.01963
- 3. Hochberg CH, Semler MW, Brower RG. Oxygen toxicity in critically ill adults. Am J Respir Crit Care Med 2021; 204(6): 632-41. https://doi.org/10.1164/rccm.202102-0417CI
- 4. Alkhuja S, Duffy K. Practice of excessive FiO2 and effect on pulmonary outcomes in mechanically ventilated patients with acute lung injury. Respir Care 2013; 58(7): e83-4. https://doi.org/10.4187/respcare.02329
- 5. Baas T, Taubenberger JK, Chong PY, Chui P, Katze MG. SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J Interferon Cytokine Res 2006; 26(5): 309-17. https://doi.org/10.1089/ jir.2006.26.309
- 6. Alejandre-Alcázar MA, Kwapiszewska G, Reiss I, Amarie OV, Marsh LM, Sevilla-Pérez J, et al. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007; 292(2): L537-49. https://doi.org/10.1152/ ajplung.00050.2006
- 7. Zhang T, Li X, Li Y, Wang H. Inhibition of TGF-β-Smad signaling attenuates hyperoxia-induced brain damage in newborn rats. Int J Clin Exp Pathol 2019; 12(10): 3772-81.
- 8. Culebras M, Loor K, Sansano I, Persiva Ó, Clofent D, Polverino E, et al. Histological findings in transbronchial cryobiopsies obtained from patients after COVID-19. Chest 2022; 161(3): 647-50. https://doi.org/10.1016/j. chest.2021.09.016
- 9. Chandel A, Patolia S, Brown AW, Collins AC, Sahjwani D, Khangoora V, et al. High-flow nasal cannula therapy in COVID-19: Using the ROX index to predict success. Respir Care 2021; 66(6): 909-19. https://doi.org/10.4187/ respcare.08631
- 10. Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: A cohort study. Am J Respir Crit Care Med 2020; 201(12): 1560-4. https://doi.org/10.1164/rccm.202004-1163LE
| APA | Yetkin N, tutar n (2022). An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. , 203 - 205. 10.5578/tt.20229811 |
| Chicago | Yetkin Nur Aleyna,tutar nuri An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. (2022): 203 - 205. 10.5578/tt.20229811 |
| MLA | Yetkin Nur Aleyna,tutar nuri An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. , 2022, ss.203 - 205. 10.5578/tt.20229811 |
| AMA | Yetkin N,tutar n An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. . 2022; 203 - 205. 10.5578/tt.20229811 |
| Vancouver | Yetkin N,tutar n An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. . 2022; 203 - 205. 10.5578/tt.20229811 |
| IEEE | Yetkin N,tutar n "An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement." , ss.203 - 205, 2022. 10.5578/tt.20229811 |
| ISNAD | Yetkin, Nur Aleyna - tutar, nuri. "An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement". (2022), 203-205. https://doi.org/10.5578/tt.20229811 |
| APA | Yetkin N, tutar n (2022). An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. Tüberküloz ve Toraks, 70(2), 203 - 205. 10.5578/tt.20229811 |
| Chicago | Yetkin Nur Aleyna,tutar nuri An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. Tüberküloz ve Toraks 70, no.2 (2022): 203 - 205. 10.5578/tt.20229811 |
| MLA | Yetkin Nur Aleyna,tutar nuri An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. Tüberküloz ve Toraks, vol.70, no.2, 2022, ss.203 - 205. 10.5578/tt.20229811 |
| AMA | Yetkin N,tutar n An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. Tüberküloz ve Toraks. 2022; 70(2): 203 - 205. 10.5578/tt.20229811 |
| Vancouver | Yetkin N,tutar n An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement. Tüberküloz ve Toraks. 2022; 70(2): 203 - 205. 10.5578/tt.20229811 |
| IEEE | Yetkin N,tutar n "An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement." Tüberküloz ve Toraks, 70, ss.203 - 205, 2022. 10.5578/tt.20229811 |
| ISNAD | Yetkin, Nur Aleyna - tutar, nuri. "An another cause of COVID-19 related pulmonary fibrosis: The high oxygen supplement". Tüberküloz ve Toraks 70/2 (2022), 203-205. https://doi.org/10.5578/tt.20229811 |
